Literature DB >> 16974027

Role of cholinesterase inhibitors in dementia care: NICE's economic analysis has limitations.

Richard J Phillips, Nick Bosanquet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16974027      PMCID： PMC1570005          DOI： 10.1136/bmj.333.7568.603

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Authors:  Colin Green; Joanna Picot; Emma Loveman; Andrea Takeda; Jo Kirby; Andrew Clegg
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.

Authors:  Nick Bosanquet; Andrew Yeates
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  Role of cholinesterase inhibitors in dementia care needs rethinking.

Authors:  Anthony J Pelosi; Seamus V McNulty; Graham A Jackson
Journal:  BMJ       Date:  2006-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.